Literature DB >> 32451498

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.

Maria Paula Roberti1,2,3, Satoru Yonekura1,2,4, Connie P M Duong1,2, Marion Picard1,2,5, Gladys Ferrere1,2, Maryam Tidjani Alou1,2, Conrad Rauber1,2,4, Valerio Iebba1,2, Christian H K Lehmann6, Lukas Amon6, Diana Dudziak6, Lisa Derosa1,2,3, Bertrand Routy1,2,4, Caroline Flament1,2,3, Corentin Richard7,8, Romain Daillère1,2, Aurélie Fluckiger1,2, Isabelle Van Seuningen9, Mathias Chamaillard10, Audrey Vincent9, Stephanie Kourula11,12, Paule Opolon1, Pierre Ly1,2, Eugénie Pizzato1,2, Sonia Becharef1,2, Juliette Paillet4,13,14, Christophe Klein13, Florence Marliot15,16, Filippo Pietrantonio17,18, Stéphane Benoist19, Jean-Yves Scoazec20, Peggy Dartigues20, Antoine Hollebecque21, David Malka21, Franck Pagès15,16, Jérôme Galon15,16, Ivo Gomperts Boneca5,22, Patricia Lepage23, Bernard Ryffel24, Didier Raoult25, Alexander Eggermont1,2,21, Tom Vanden Berghe11,12, François Ghiringhelli7,8, Peter Vandenabeele11,12,26, Guido Kroemer13,14,27,28,29, Laurence Zitvogel30,31,32,33,34.   

Abstract

The prognosis of colon cancer (CC) is dictated by tumor-infiltrating lymphocytes, including follicular helper T (TFH) cells and the efficacy of chemotherapy-induced immune responses. It remains unclear whether gut microbes contribute to the elicitation of TFH cell-driven responses. Here, we show that the ileal microbiota dictates tolerogenic versus immunogenic cell death of ileal intestinal epithelial cells (IECs) and the accumulation of TFH cells in patients with CC and mice. Suppression of IEC apoptosis led to compromised chemotherapy-induced immunosurveillance against CC in mice. Protective immune responses against CC were associated with residence of Bacteroides fragilis and Erysipelotrichaceae in the ileum. In the presence of these commensals, apoptotic ileal IECs elicited PD-1+ TFH cells in an interleukin-1R1- and interleukin-12-dependent manner. The ileal microbiome governed the efficacy of chemotherapy and PD-1 blockade in CC independently of microsatellite instability. These findings demonstrate that immunogenic ileal apoptosis contributes to the prognosis of chemotherapy-treated CC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32451498     DOI: 10.1038/s41591-020-0882-8

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  53 in total

1.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 2.  The multifaceted role of the intestinal microbiota in colon cancer.

Authors:  Thergiory Irrazábal; Antoaneta Belcheva; Stephen E Girardin; Alberto Martin; Dana J Philpott
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

3.  Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis.

Authors:  Abby L Geis; Hongni Fan; Xinqun Wu; Shaoguang Wu; David L Huso; Jaime L Wolfe; Cynthia L Sears; Drew M Pardoll; Franck Housseau
Journal:  Cancer Discov       Date:  2015-07-22       Impact factor: 39.397

4.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Authors:  Franck Pagès; Bernhard Mlecnik; Florence Marliot; Gabriela Bindea; Fang-Shu Ou; Carlo Bifulco; Alessandro Lugli; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Mihaela Angelova; Angela Vasaturo; Pauline Maby; Sarah E Church; Helen K Angell; Lucie Lafontaine; Daniela Bruni; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Jeffrey P Meyers; Christopher Paustian; Zipei Feng; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Mușină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Daniel J Sargent; Bernard A Fox; Jérôme Galon
Journal:  Lancet       Date:  2018-05-10       Impact factor: 79.321

Review 5.  Microbes, microbiota, and colon cancer.

Authors:  Cynthia L Sears; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

6.  Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer.

Authors:  Weiguang Chen; Fanlong Liu; Zongxin Ling; Xiaojuan Tong; Charlie Xiang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

7.  Gut mucosal microbiome across stages of colorectal carcinogenesis.

Authors:  Geicho Nakatsu; Xiangchun Li; Haokui Zhou; Jianqiu Sheng; Sunny Hei Wong; William Ka Kai Wu; Siew Chien Ng; Ho Tsoi; Yujuan Dong; Ning Zhang; Yuqi He; Qian Kang; Lei Cao; Kunning Wang; Jingwan Zhang; Qiaoyi Liang; Jun Yu; Joseph J Y Sung
Journal:  Nat Commun       Date:  2015-10-30       Impact factor: 14.919

8.  Gut microbiota and colon cancer: the carbohydrate link.

Authors:  Antoaneta Belcheva; Alberto Martin
Journal:  Mol Cell Oncol       Date:  2014-11-11

9.  Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.

Authors:  Azadeh Saffarian; Céline Mulet; Béatrice Regnault; Aurélien Amiot; Jeanne Tran-Van-Nhieu; Jacques Ravel; Iradj Sobhani; Philippe J Sansonetti; Thierry Pédron
Journal:  mBio       Date:  2019-07-16       Impact factor: 7.867

10.  Diversified pattern of the human colorectal cancer microbiome.

Authors:  Jiawei Geng; Hong Fan; Xiaodan Tang; Huiqin Zhai; Zhigang Zhang
Journal:  Gut Pathog       Date:  2013-03-07       Impact factor: 4.181

View more
  40 in total

1.  Inosine: novel microbiota-derived immunostimulatory metabolite.

Authors:  Guido Kroemer; Laurence Zitvogel
Journal:  Cell Res       Date:  2020-11       Impact factor: 25.617

Review 2.  Immunogenic cell stress and death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Claudia Galassi; Laurence Zitvogel
Journal:  Nat Immunol       Date:  2022-02-10       Impact factor: 25.606

3.  Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.

Authors:  Can Cui; Jiawei Wang; Eric Fagerberg; Ping-Min Chen; Kelli A Connolly; Martina Damo; Julie F Cheung; Tianyang Mao; Adnan S Askari; Shuting Chen; Brittany Fitzgerald; Gena G Foster; Stephanie C Eisenbarth; Hongyu Zhao; Joseph Craft; Nikhil S Joshi
Journal:  Cell       Date:  2021-11-30       Impact factor: 41.582

4.  Comprehensive Analysis of the Potential Immune-Related Biomarker ATG101 that Regulates Apoptosis of Cholangiocarcinoma Cells After Photodynamic Therapy.

Authors:  Zi-Jian Zhang; Kun-Peng Wang; Yun-Peng Huang; Chong Jin; Hao Jiang; Li Xiong; Zhao-Yi Chen; Yu Wen; Zhong-Tao Liu; Jing-Gang Mo
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

Review 5.  Targeting the gut microbiota for cancer therapy.

Authors:  Miriam R Fernandes; Poonam Aggarwal; Raquel G F Costa; Alicia M Cole; Giorgio Trinchieri
Journal:  Nat Rev Cancer       Date:  2022-10-17       Impact factor: 69.800

Review 6.  Targeting the gut and tumor microbiota in cancer.

Authors:  Elizabeth M Park; Manoj Chelvanambi; Neal Bhutiani; Guido Kroemer; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

Review 7.  The microbiome and human cancer.

Authors:  Gregory D Sepich-Poore; Laurence Zitvogel; Ravid Straussman; Jeff Hasty; Jennifer A Wargo; Rob Knight
Journal:  Science       Date:  2021-03-26       Impact factor: 47.728

Review 8.  The inflammatory pathogenesis of colorectal cancer.

Authors:  Mark Schmitt; Florian R Greten
Journal:  Nat Rev Immunol       Date:  2021-04-28       Impact factor: 53.106

Review 9.  Beneficial autoimmunity improves cancer prognosis.

Authors:  Laurence Zitvogel; Claude Perreault; Olivera J Finn; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2021-05-11       Impact factor: 65.011

10.  Artesunate combined with verteporfin inhibits uveal melanoma by regulation of the MALAT1/yes-associated protein signaling pathway.

Authors:  Xudong Jiu; Yang Liu; Jin Wen
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.